BioMarin Pharmaceutical Inc.
$BMRN
Public valuation for BioMarin Pharmaceutical Inc. (BMRN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$60.02
18% Undervalued
Fair Value Estimate
$71
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $87.92
46% higher than current
Key Metrics
Market Cap
$11.6B
Forward P/E
12.4x
Operating Margin
16.9%
Revenue Growth
8.0%
PEG Ratio
0.67
Get free watchlist alerts
Join the waitlist for valuation updates on $BMRN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.